1-hour Premedication for Allergy Goal in Emergency: PAGE-1 Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorPaul Peng, MD PhD MSCR

About this trial

1-hour Premedication for Allergy Goal in Emergency: PAGE-1 is a prospective, parallel, two-arm, non-inferiority, randomized controlled trial evaluating the safety of a 1-hour (intervention) versus a 4-hour (standard regimen) intravenous (IV) premedication protocol in adult patients in the Emergency Department (ED) with a documented iodinated contrast allergy and requiring computed tomography (CT) imaging for a high-risk indication.

Eligibility criteria

Qualifiers

Adult (≥ 21 years old)

Documented iodinated contrast allergy in the electronic health record

CT with iodinated contrast ordered for a high-risk indication, † defined as post-arrest, concern for aortic dissection, ischemia, occlusion, obstruction, or other life-threatening conditions requiring timely diagnosis

Willing and able to give consent

Disqualifiers

Previous enrollment in this study

Pregnancy

Seafood or iodine allergy, alone

Gadolinium allergy

Trial design

Treatments tested in this trial

  • IV glucocorticoid and antihistamine
  • IV glucocorticoid and antihistamine (standard of care)

Treatment groups

540 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Paul Peng, MD PhD MSCR

Lead sponsor

Rutgers, The State University of New Jersey

Sponsor institution